Once integration is completed, the partners plan to accelerate commercial rollout across India, anticipated in 2026.

Cardio Diagnostics Holdings will partner with a longtime distribution leader in India and an Indian network of nearly 300 ...

Cardio Diagnostics Holdings Inc. (NASDAQ:CDIO), an AI-powered precision cardiovascular medicine company, is making progress in gaining broad access to Medicare reimbursement for its Epi+Gen CHD™ and ...

This surprisingly simple walking test is becoming a go-to tool for measuring real cardiovascular fitness—no gym, no gadgets, ...

CHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings Inc (Nasdaq: CDIO), an artificial intelligence-powered precision cardiovascular medicine company, today announced the launch of PrecisionCHD™, an ...

Try this 10-minute walking test to see how many steps you can take and what your result says about cardio fitness.

High cholesterol and age are two significant risk factors for heart disease, which is the leading cause of death in the ...

One of the strongest predictors of long-term mortality among patients undergoing a cardiac stress test is the need for a pharmacologic versus treadmill test, new data show. Moreover, although the risk ...

Investing.com -- Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) stock rose 9.3% in premarket trading Wednesday after the ...